Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
2
×
boston blog main
boston top stories
2
×
clinical trials
dyne therapeutics
life sciences
myotonic dystrophy type 1
national blog main
rare disease drugs
san diego blog main
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
biotech ipos
bluebird bio
duchenne muscular dystrophy
facioscapulohumeral muscular dystrophy
fda
gene therapy
joshua brumm
kaleido biosciences
metacrine
muscular dystrophy
national top stories
new york blog main
nonalcoholic steatohepatitis
rare diseases
romesh subramanian
salk institute
san diego top stories
san francisco blog main
susanna high
ulcerative colitis
vertex pharmaceuticals
What
drug
dyne
2
×
genetic
ipo
medicines
muscle
2
×
rare
therapeutics
ago
biotechs
brings
company
considering
data
developing
diseases
disorders
dyne’s
early
expected
experimental
eyes
having
humans
ipos
long
million
muscular
preclinical
raised
reach
stage
topped
upsized
worked
Language
unset
Current search:
muscle
×
boston
×
" boston top stories "
×
dyne
×
@xconomy.com
4 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
4 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
